Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apathy in Dementia Methylphenidate Trial 2
NCT02346201Phase 3Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Jan 2016
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of methylphenidate in apathy, sponsored by Johns Hopkins Bloomberg School of Public Health. Started Jan 2016; status: completed.
02
Drugs
methylphenidate
03
Conditions
apathy
Beyond the preview
Go deeper on NCT02346201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02346201.